Rozprawy doktorskie na temat „Dendritic cell”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych rozpraw doktorskich naukowych na temat „Dendritic cell”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj rozprawy doktorskie z różnych dziedzin i twórz odpowiednie bibliografie.
Carnathan, Diane Gail Vilen Barbara J. "Dendritic cell regulation of B cells". Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2007. http://dc.lib.unc.edu/u?/etd,1200.
Pełny tekst źródłaTitle from electronic title page (viewed Mar. 26, 2008). "... in partial fulfillment of the requirements for the degree of Master of Science in the Department of Microbiology and Immunology, School of Medicine." Discipline: Microbiology and Immunology; Department/School: Medicine.
Liu, Hao. "Dendritic cell development directed by stromal cells". Thesis, University of York, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516409.
Pełny tekst źródłaGreensmith, Julie. "The dendritic cell algorithm". Thesis, Nottingham Trent University, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444619.
Pełny tekst źródłaKavikondala, Sushma. "Dendritic cell and B cell interactions in systemic lupuserythematosus". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B39793710.
Pełny tekst źródłaKavikondala, Sushma. "Dendritic cell and B cell interactions in systemic lupus erythematosus". View the Table of Contents & Abstract, 2007. http://sunzi.lib.hku.hk/hkuto/record/B39711523.
Pełny tekst źródłaRigby, Rachael Jane. "Intestinal dendritic cells : characterisation of the colonic dendritic cell population and identification of potential precursors". Thesis, Imperial College London, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.407134.
Pełny tekst źródłaJavorovic, Miran. "T-Cell Stimulation by Melanoma RNA-Pulsed Dendritic Cells". Diss., lmu, 2004. http://nbn-resolving.de/urn:nbn:de:bvb:19-30569.
Pełny tekst źródłaPérez, Zsolt Daniel. "New therapeutic strategies targeting dendritic cell-mediated dissemination of enveloped viruses". Doctoral thesis, Universitat Autònoma de Barcelona, 2020. http://hdl.handle.net/10803/669547.
Pełny tekst źródłaLas células dendríticas (DCs) son clave en la inducción de respestas inmunitarias adaptativas gracias a su capacidad de capturar, procesar y presentar antígenos derivados de patógenos a los linfocitos T. Sin embargo, estas células también podrían contribuir a la diseminación inicial del VIH-1 a través de la captura de partículas virales y de su transmisión a las células T CD4+ diana, un proceso conocido como trans-infección. Este mecanismo se basa en la expresión del receptor Siglec-1 (CD169), que reconoce gangliósidos sialilados en la membrana viral. Los niveles de Siglec-1 aumentan en DCs estimuladas con interferón-alfa (IFN-α) y lipopolisacárido (LPS), factores immuno-activadores presentes durante el curso de la infección por VIH-1. En este trabajo, hemos demostrado que el IFN-α secretado por DCs plasmacitoides (pDCs) infectadas por VIH-1, así como el IFN-α autocrino secretado por células mieloides en respuesta a LPS, aumentan la expresión de Siglec-1 en DCs. Además, las pDCs provenientes de mujeres secretan cantidades superiores de IFN-α que las derivadas de hombres, poniendo de manifiesto la relevancia de estudiar la trans-infección del VIH-1 en tejidos clave para la adquisición del virus en mujeres. Por lo tanto, también hemos estudiado el papel de Siglec-1 en la transmisión del VIH-1 por parte de DCs primarias aisladas directamente de tejido cervical, identificando una población de DCs cervicales que expresan Siglec-1 y capturan partículas de VIH-1 a través de este receptor. Esta capacidad aumenta con la activación por IFN-α. Además, la transmisión célula-célula del VIH-1 por células mieloides del cérvix se puede bloquear de forma eficiente con un anticuerpo monoclonal (mAb) dirigido contra Siglec-1. Se han producido cinco nuevos clones, que han demostrado tener una alta afinidad por diferentes epítopos localizados en la región N-terminal de Siglec-1. Además, bloquean de forma eficaç la captura y trans-infección del VIH-1 por DCs, de forma que podrían ser un posible componente en estrategias microbicidas dirigidas contra este tipo de transmisión viral célula-célula. Además del VIH-1, las DCs pueden jugar un papel importante en la patogénesis de otros virus, como los filovirus Ébola y Marburg. A diferencia del VIH-1, las DCs son permisivas a la infección por filovirus y son dianas tempranas en lapatogénesis viral. Los factores celulares implicados en la entrada de filovirus en DCs no han sido totalmente caracterizados, pero tanto Ébola como Marburg son virus envueltos que incorporan gangliósidos sialilados durante el proceso de budding. Además, los factores que activan la expresión de Siglec-1 como IFN-α y LPS se han encontrado durante la infección por el virus de Ébola. Por tanto, en esta tesis hemos estudiado el papel de Siglec-1 en la entrada de filovirus en DCs. Hemos encontrado que Siglec-1 está implicado en la captura de partículas no infecciosas de Ébola (VLPs) por parte de estas células, especialmente tras la activación por IFN-α y LPS. Además, las VLPs capturadas se acumulan en el mismo compartimento en el que previamente se había detectado VIH-1. Siglec-1 también facilita la entrada citoplásmica del virus en las DCs, así que hemos determinado la capacidad de los nuevos mAbs contra Siglec-1 para interferir en este proceso, y hemos visto que dichos mAbs bloquean tanto la captura como la entrada citoplásmica de VLPs de Ébola en células mieloides activadas. En general, la actividad de los mAbs contra Siglec-1 inhibe el acceso de retrovirus y filovirus en las células mieloides, cosa que indica su potencial uso como agentes antivirales de amplio espectro.
Dendritic cells are key inducers of specific adaptive immune responses due to their capacity to capture, process and present pathogen-derived antigens to T lymphocytes. However, they might also contribute to early HIV-1 dissemination by capturing HIV-1 particles and transmitting them to target CD4+ T cells, a process known as trans-infection. This mechanism relies on the expression of Siglec-1 receptor (CD169), which recognizes sialylated gangliosides on the viral membrane. Siglec-1 is potently up-regulated upon dendritic cell stimulation with interferon-alpha and lipopolysaccharide, which are both immune-activating factors present during the course of HIV-1 infection. Here, we demonstrated that interferon-alpha secreted by HIV-1-infected plasmacytoid dendritic cells and autocrine interferon-alpha secreted by myeloid cells in response to lipopolysaccharide up-regulate Siglec-1 on dendritic cells. Importantly, plasmacytoid dendritic cells derived from women secreted higher amounts of interferon-alpha than those derived from men, highlighting the relevance of studying HIV-1 trans-infection in key female tissues for HIV-1 acquisition. Thus, we next studied the role of Siglec-1 in HIV-1 transmission mediated by primary dendritic cells directly isolated from cervical tissues, identifying a subset of cervical myeloid cells that expressed Siglec-1 and captured HIV-1 particles in a Siglec-1-dependent manner. This capacity was enhanced upon activation with interferon-alpha. Moreover, HIV-1 cell-to-cell transmission mediated by these cells could be efficiently blocked using an anti-Siglec-1 monoclonal antibody, indicating the potential use of antibodies directed against Siglec-1 in prevention of sexually transmitted HIV-1 acquisition in women. Thus, we generated a set of new anti-Siglec-1 monoclonal antibodies with the capacity to block dendritic cell-mediated HIV-1 trans-infection. Five new clones were produced, demonstrating high affinity for different epitopes located in the N-terminal region of Siglec-1 receptor. Moreover, they efficiently blocked HIV-1 capture and trans-infection mediated by dendritic cells, indicating their potential use in microbicidal strategies targeting this type of viral cell-to-cell transmission. Aside from HIV-1, dendritic cells can play important roles in the pathogenesis of other viruses, including Ebola and Marburg filoviruses. In contrast to HIV-1, dendritic cells are permissive to filoviral infection and act as early targets in viral pathogenesis. The host factors governing filoviral entry into these cells are not fully characterized, but both Ebola and Marburg are enveloped viruses that incorporate sialylated gangliosides during the budding process. Moreover, Siglec-1-activating factors such as interferon-alpha and lipopolysaccharide have been found during Ebola virus disease. Thus, we investigated the role of Siglec-1 in filoviral entry into dendritic cells. We found that Siglec-1-mediated capture of non-infectious Ebola virus-like particles into these cells, especially upon interferon-alpha and lipopolysaccharide activation. Interestingly, captured Ebola virus-like particles accumulated in the same cellular compartment where HIV-1 was previously detected. Siglec-1 also facilitated Ebola cytoplasmic entry into dendritic cells, so we tested the capacity of novel anti-Siglec-1 monoclonal antibodies to interfere with this process. We found that capture and cytoplasmic entry of Ebola virus-like particles into activated myeloid cells was blocked by these novel antibodies. Overall, the activity of anti-Siglec-1 monoclonal antibodies inhibits the access of both retroviruses and filoviruses into myeloid cells and suggests their potential use as broad-spectrum antiviral agents.
Sarris, Milka. "Dynamics of helper T cell and regulatory T cell interactions with dendritic cells". Thesis, University of Cambridge, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.611896.
Pełny tekst źródłaMahmood, Sajid. "Diverse regulation of natural killer cell functions by dendritic cells". Public Library of Science, 2012. http://hdl.handle.net/1993/23963.
Pełny tekst źródłaOctober 2014
Talay, Oezcan. "Efficient dendritic cell maturation and initiation of a strong T cell immune response requires B7-H1-mediated dendritic cell 'conditioning' during interaction with T cells". [S.l. : s.n.], 2008. http://nbn-resolving.de/urn:nbn:de:bsz:16-opus-89195.
Pełny tekst źródłaLu, Tangying (Lily). "Cannabinoids suppress dendritic cell-induced T helper cell polarization". [Tampa, Fla] : University of South Florida, 2006. http://purl.fcla.edu/usf/dc/et/SFE0001790.
Pełny tekst źródłaChagnon, Fanny. "A dendritic cell vaccine for murine renal cell carcinoma". Thesis, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=19400.
Pełny tekst źródłaSPREAFICO, ROBERTO. "Mechanisms of dendritic cell-mediated natural killer cell activation". Doctoral thesis, Università degli Studi di Milano-Bicocca, 2010. http://hdl.handle.net/10281/10317.
Pełny tekst źródłaWurzenberger, Cornelia. "Dendritic cell vaccines in tumor immunotherapy". Diss., lmu, 2009. http://nbn-resolving.de/urn:nbn:de:bvb:19-95530.
Pełny tekst źródłaSuri, Rakesh Mark. "Dendritic cell maturation, migration and function". Thesis, University of Oxford, 1998. https://ora.ox.ac.uk/objects/uuid:47d2be37-0508-47d6-8b97-a3cf8e39f9f6.
Pełny tekst źródłaGroot, Fedde. "Dendritic cell-mediated hiv-1 transmission". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2006. http://dare.uva.nl/document/36281.
Pełny tekst źródłaMorel, Anne-Sophie. "Manipulation of human dendritic cell function". Thesis, Imperial College London, 1999. http://hdl.handle.net/10044/1/11840.
Pełny tekst źródłaNetravali, Ilka Arun. "Elucidation of plasmacytoid dendritic cell development". Thesis, Harvard University, 2014. http://dissertations.umi.com/gsas.harvard:11311.
Pełny tekst źródłaWhelan, Kathryn Theresa. "Dendritic cell function in HIV disease". Thesis, University of Oxford, 2003. http://ora.ox.ac.uk/objects/uuid:15b65f1c-4d92-48ec-bcab-aecc92dc674c.
Pełny tekst źródłaMeltzer, Ulrike Anne. "Dendritic cell maturation and antigen presentation". Thesis, University College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.407647.
Pełny tekst źródłaUronen-Hansson, Heli Anneli. "Dendritic cell interactions with neisseria meningitidis". Thesis, University College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405680.
Pełny tekst źródłaKim, Jong-won. "Signalling initiation by blood dendritic cell antigen 2, a novel immunoglobulin receptor on plasmacytoid dendritic cells". Thesis, Imperial College London, 2018. http://hdl.handle.net/10044/1/63862.
Pełny tekst źródłaSmits, Hermelijn Hélène. "Instruction of effector T cell programs by flexible dendritic cells". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2003. http://dare.uva.nl/document/86946.
Pełny tekst źródłaDrakesmith, Alexander Hal. "Antigen processing and T cell priming by mouse dendritic cells". Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.300533.
Pełny tekst źródłaStuart, Lynda Maria. "Cell death, dendritic cells and downregulation of the immune response". Thesis, University of Edinburgh, 2003. http://hdl.handle.net/1842/23214.
Pełny tekst źródłaEaton, Laura. "Skin dendritic cells : activation, maturation and migration". Thesis, University of Manchester, 2012. https://www.research.manchester.ac.uk/portal/en/theses/skin-dendritic-cells-activation-maturation-and-migration(0831ed5e-c580-406c-a404-4b1eb59b040d).html.
Pełny tekst źródłaThompson, Angus Gordon. "Dendritic cell NFkB function in T cell activation and autoimmunity /". [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18273.pdf.
Pełny tekst źródłaSchnorfeil, Frauke Marie. "MicroRNAs regulate Dendritic Cell Development and Function". Diss., lmu, 2011. http://nbn-resolving.de/urn:nbn:de:bvb:19-137930.
Pełny tekst źródłaNaik, Shalin Hemant. "Distinct precursors of the dendritic cell subtypes /". Connect to thesis, 2006. http://eprints.unimelb.edu.au/archive/00001885.
Pełny tekst źródłaBurns, Siobhan Oisn. "Dendritic cell defects in Wiskott-Aldrich syndrome". Thesis, University College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.252178.
Pełny tekst źródłaBruckner, Markus [Verfasser]. "Modulation of Dendritic Cell Behaviour / Markus Bruckner". Konstanz : Bibliothek der Universität Konstanz, 2011. http://d-nb.info/1041832877/34.
Pełny tekst źródłaChe, Karlhans Fru. "Immunomodulatory Effects of Human ImmunodeficiencyVirus (HIV-1) on Dendritic Cell and T cell Responses : Studies of HIV-1 effects on Dendritic cell functionality reflected in primed T cells". Doctoral thesis, Linköpings universitet, Molekylär virologi, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-71279.
Pełny tekst źródłaRaïch, Regué Dàlia. "Generation of Tolerogenic Dendritic Cells for Cell Therapy in Multiple Sclerosis". Doctoral thesis, Universitat Autònoma de Barcelona, 2012. http://hdl.handle.net/10803/96710.
Pełny tekst źródłaMultiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system. Current treatments for relapsing-remitting multiple sclerosis (RR-MS) patients decrease the frequency of relapses and reduce inflammatory activity in a nonspecific manner, but their effect on disease progression is still unclear. Therefore, in order to modify the course of MS, new and more specific therapeutic approaches are necessary. Specific inhibition or deletion of autoreactive T cells represents an interesting goal for restoring peripheral tolerance in autoimmune diseases such as MS. The main goal of this work has been to generate and characterize tolerogenic dendritic cells (tolDCs) from RR-MS patients, loaded with myelin peptides as specific antigen, as a therapeutic tool to re-establish tolerance to myelin-antigens in these patients. Our results show that using different immunosuppressive drugs and different maturation stimulus led to the generation of clinical-grade tolDCs products with differences that are relevant to therapeutic applicability. We evaluated the viability, phenotype, cytokine profile, stability and functionality of these tolDCs. The comparison of different pharmacological grade tolerogenic agents (dexamethasone, rapamycin and vitamin-D3) led to the observation that dexamethasone-treated DCs showed a semi-mature phenotype and high IL-10 secretion; that rapamycin-treated DCs impaired IFN-γ in co-cultured T cells and expanded T regulatory cells; and finally that vitamin-D3-treated DCs presented a semi-mature phenotype, produced IL-10, and reduced IFN-γ in T cells. These features, along with their reproducibility among different samples, made consider vitamin-D3 as the most convenient of the three compared agents to generate tolDCs for MS therapy. Regarding the maturation of tolDCs, the cytokine cocktail (composed by TNF-α, IL-1β and PGE-2) was determined as the optimal maturation stimulus to generate tolDCs (induced by vitamin-D3 treatment), since these tolDCs were the unique exhibiting functional stability and capability to suppress an immune response in vitro. The generation and characterization of tolDCs from RR-MS patients (generated with vitD3 and maturated with the pro-inflammatory cytokine cocktail), showed no significant differences compared with tolDCs generated from healthy controls, both presenting a tolerogenic profile. Importantly, myelin peptide-loaded tolDCs from RR-MS patients induced antigen-specific and stable hyporesponsiveness in autologous myelin-reactive T cells in vitro. Altogether this work has conducted to the development of a protocol to generate clinical-grade tolDCs and set up the bases for their use as a therapeutic tool to re-establish tolerance in RR-MS patients.
Barroso, Herrera Osquel Miguel. "Manipulation of antigen-specific T cell responses by modified dendritic cells". Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405941.
Pełny tekst źródłaWorsley, Alan G. F. "T-cell polarisation by dendritic cells : a role for Notch ligands?" Thesis, University of Edinburgh, 2009. http://hdl.handle.net/1842/3281.
Pełny tekst źródłaWilliams, Charlotte Anne. "The immunoregulatory role of dendritic cells in response to cell deaths". Thesis, University of the West of England, Bristol, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444498.
Pełny tekst źródłaHu, Yang. "Regulation of dendritic cell and monocyte migration by interferons /". Access full-text from WCMC:, 2006. http://proquest.umi.com/pqdweb?did=1296095631&sid=1&Fmt=2&clientId=8424&RQT=309&VName=PQD.
Pełny tekst źródłaSampangi, Sandeep. "Autologous human kidney proximal tubule epithelial cells (PTEC) modulate dendritic cell (DC), T cell and B cell responses". Thesis, Queensland University of Technology, 2015. https://eprints.qut.edu.au/82033/1/Sandeep_Sampangi_Thesis.pdf.
Pełny tekst źródłaKalogeropoulos, Michail. "Novel mechanisms of dendritic cell regulation by leukocyte immunoglobulin-like receptor B1". Thesis, University of Aberdeen, 2014. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=210082.
Pełny tekst źródłaMohib, Kanishka. "Embryonic Stem Cell Extracts Possess Immune Modulatory Properties That Prevent Dendritic Cell Maturation and T Cell Activation". Thèse, Université d'Ottawa / University of Ottawa, 2012. http://hdl.handle.net/10393/22794.
Pełny tekst źródłaGoddard, Ruth Victoria. "Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells". Thesis, University of Plymouth, 2002. http://hdl.handle.net/10026.1/2695.
Pełny tekst źródłaKanazawa, Nobuo. "Fractalkine and macrophage-derived chemokine : T cell attracting chemokines expressed in T cell area dendritic cells". Kyoto University, 2000. http://hdl.handle.net/2433/180886.
Pełny tekst źródłaHu, Yaling. "Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells /". View abstract or full-text, 2008. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202008%20HU.
Pełny tekst źródłaValentin-Torres, Alice M. "Bidirectional Natural Killer Cell and Dendritic Cell Interactions in HIV-1 Pathogenesis". Case Western Reserve University School of Graduate Studies / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=case1346268879.
Pełny tekst źródłaCabezón, Cabello Raquel. "Tolerogenic dendritic cell-based immunotherapy in Crohn’s disease". Doctoral thesis, Universitat de Barcelona, 2015. http://hdl.handle.net/10803/310604.
Pełny tekst źródłaEsta tesis doctoral estudia el proceso de generación de células dendríticas tolerogénicas en grado clínico, con el objetivo de establecer un protocolo destinado al tratamiento de la enfermedad de Crohn. El estudio realizado ha permitido la caracterización de dichas células y sus propiedades tolerogénicas, incluyendo la descripción novedosa de un marcador de células tolerogénicas y el estudio de sus propiedades funcionales relacionadas con la inducción de tolerancia.
Milne, Paul. "Dendritic cell development in haematological malignancies and neoplasia". Thesis, University of Newcastle upon Tyne, 2015. http://hdl.handle.net/10443/3015.
Pełny tekst źródłaBurke, Fiona. "Characterisation of dendritic cell subsets and their interactions". Thesis, Imperial College London, 2004. http://hdl.handle.net/10044/1/11955.
Pełny tekst źródłaAdikari, Sanjaya Bandara. "Cytokine-modulated dendritic cell immunotherapy in autoimmune diseases /". Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-149-0/.
Pełny tekst źródłaStamataki, Zacharenia. "Identification and characterisation of folllicular dendritic cell subsets". Thesis, Imperial College London, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.417698.
Pełny tekst źródła